I+Med secures €72 million in funding for a major bioscience and healthcare project in Biscay, aiming to create over 600 jobs over three years.
Amount Raised
€72 Million
Round Type
Venture
Description
I+Med is leading a significant bioscience and healthcare project involving a total investment of €72 million. This project will allocate €28 million specifically for R&D efforts. The initiative is expected to create more than 600 jobs in the region. The investment is part of Biscay's broader strategy to boost its startup ecosystem and public investments in innovative sectors.
Quick answer
I+Med raised €72 Million in a funding round, dated November 11, 2026. I+Med is based in Autonomous Community Of The Basque Country, Spain.
- How much did I+Med raise?
- I+Med raised €72 Million in a funding round on November 11, 2026.
- What does I+Med do?
- Biscay (Bizkaia) is developing a vibrant startup ecosystem by leveraging its industrial heritage and focusing on biotechnology, advanced manufacturing, energy, and emerging technologies.
- Where is I+Med based and how big is it?
- I+Med is based in Autonomous Community Of The Basque Country, Spain.
Source: Fundz verified event record.
Who to call at I+Med, and when
A new round usually means I+Med is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day I+Med raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at I+Med, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at I+Med. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment I+Med raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
I+Med raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.